Evelo Biosciences
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Evelo Biosciences's balance sheet done over the years? Its assets were worth $64,441,000 last year, which is less than in the previous period. 108% of Evelo Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $69,433,000, which means an decrease by -12% compared compared to last year.

Debt to Assets

Evelo Biosciences, Inc. (NASDAQ:EVLO): Debt to assets
2016 18570000 13.04M 70.24%
2017 43788000 14.38M 32.85%
2018 159867000 22.91M 14.34%
2019 90920000 30.72M 33.79%
2020 90639000 60.15M 66.37%
2021 87871000 79.20M 90.14%
2022 64441000 69.43M 107.75%

EVLO Balance Sheet (2016 – 2022)

2022 2021 2020 2019 2018 2017 2016
Assets
Current assets:
Cash and cash equivalents
47.94M68.44M68.85M77.83M147.91M38.24M15.53M
Short term investments
000054.81M00
Net receivables
0000000
Inventory
0000000
Other current assets
3.63M2.58M2.12M3.17M3.70M531K184K
Total current assets
51.57M71.02M68.85M77.83M147.91M38.77M15.72M
Non-current assets:
Property, Plant and Equipment
11.71M15.53M18.23M8.34M6.92M3.49M2.50M
Goodwill
0000000
Intangible assets
0000000
Long term investments
0000000
Other non-current assets
1.15M1.31M3.54M4.74M5.02M1.51M346K
Total non-current assets
12.86M16.84M21.78M13.08M11.94M5.01M2.85M
Total assets
64.44M87.87M90.63M90.92M159.86M43.78M18.57M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
7.5M13.06M-2.13M0000
Short term debt
2.25M1.95M1.67M0000
Total current liabilities
12.39M17.36M19.83M9.74M9.23M3.83M2.24M
Non-current liabilities:
Long term debt
48.87M54.34M40.03M19.63M12.30M9.96M9.93M
Deferred tax
0000000
Other non-current liabilities
659K7.5M284K1.34M1.37M580K865K
Total non-current liabilities
57.03M61.84M40.32M20.98M13.68M10.54M10.79M
Total liabilities
69.43M79.20M60.15M30.72M22.91M14.38M13.04M
Data sourceData sourceData sourceData sourceData source